About Bayer Zydus Pharma Private Limited
Data last updated:
Bayer Zydus Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2011PTC213118. Its GSTIN is 27AAECB4156B1Z2 (Maharashtra). The company holds 30 GST registrations, of which 22 are active.
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹50 Cr. It is led by directors Shweta Rai (Managing Director) and Sunil Prakashlal Narwani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bayer House Central Avenue Hiranandani Estate Thane (West), Maharashtra, India – 400607.
As per the financials filed for FY 2025, the company reported a revenue of ₹619.33 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹56.1 Cr (net margin 9.1%) and EBITDA of ₹94.75 Cr (EBITDA margin 15.3%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 10% over five years.
The company has about 713 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Bayer Zydus Pharma. Court records list 12 cases involving the company, including 8 filed by the company and 4 filed against it; 3 cases are pending. The company has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹101.49 Cr; the latest was in June 2024. Its 6 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 3 smaller; the largest is Skites Pharma Private Limited with revenue of ₹661.04 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 53 overdue payments to 14 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bayerzyduspharma.com.
Company details
Contact details
Bayer Zydus Pharma Private Limited's registered office is in Thane, Maharashtra. Its website is bayerzyduspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressBayer House Central Avenue Hiranandani Estate Thane (West), Maharashtra, India – 400607
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bayer Zydus Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Bayer Zydus Pharma operates one associated brand: Bayer Zydus Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharmaceuticals for diabetes, cardiology, women's health, and oncology in India. | bayerzyduspharma.com |
Business activity
The main business activity of Bayer Zydus Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bayer Zydus Pharma Private Limited, buy the company report.
Financials of Bayer Zydus Pharma Private Limited
FY 2025 filings availableBayer Zydus Pharma Private Limited reported revenue of ₹619.33 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 23% growth in the latest year. EBITDA rose 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94.75 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.3% | ||||
| Net Profit Margin | 9.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bayer Zydus Pharma Private Limited, buy the company report.
Board of directors of Bayer Zydus Pharma Private Limited
Bayer Zydus Pharma has 2 current directors and 30 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shweta Rai Also directs: Bayer Pharmaceuticals Private Limited | Managing Director | 14 Dec 2023 | 2 Years 10 Months | Current |
| Sunil Prakashlal Narwani | Additional Director | 26 May 2025 | 1 Years 5 Months | Current |
Peer comparison
Bayer Zydus Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Skites Pharma Private Limited | ₹661.04 Cr (FY 2025) | -17.0% | Mumbai, Maharashtra, India | |||
| Dhruvi Healthcare Private Limited | ₹634.47 Cr (FY 2025) | 22.0% | Ahmedabad, Gujarat, India | |||
| Vardhman Health Specialities Private Limited | ₹624.18 Cr (FY 2025) | 9.0% | Bangalore, Karnataka, India | |||
| Bayer Zydus Pharma Private Limitedthis company | ₹619.33 Cr (FY 2025) | ₹56.1 Cr | 9.1% | 23.0% | 713 | Thane, Maharashtra, India |
| Auro Enterprises(India)Private Limited | ₹616.87 Cr (FY 2025) | 2724.0% | Hyderabad, Telangana, India | |||
| Arihant Innochem Private Limited | ₹589.9 Cr (FY 2025) | 35.0% | Mumbai, Maharashtra, India | |||
| Vasu Agencies Hyd Private Limited | ₹539.98 Cr (FY 2023) | 3.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Bayer Zydus Pharma Private Limited, buy the company report.
Auditor
Bayer Zydus Pharma Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2023 | 117366W/W-100018 |
Shareholding
The shareholding of Bayer Zydus Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bayer Zydus Pharma Private Limited, buy the company report.
Deals & funding
Bayer Zydus Pharma Private Limited has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹101.49 Cr; the latest was in June 2024.
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2024 | Secondary share transfer | Undisclosed | Seller: Bayer Pharmaceuticals Private Limited |
| May 2024 | Secondary share transfer | Undisclosed | Seller: Bayer Pharmaceuticals Private Limited |
| May 2024 | Secondary share transfer | Undisclosed | Buyer: Bayer Pharmaceuticals Private Limited Seller: Zydus Lifesciences Limited |
| May 2024 | Secondary share transfer | Undisclosed | Seller: Zydus Lifesciences Limited |
| Jun 2021 | Secondary share transfer | Undisclosed | Seller: Bayer Pharmaceuticals Private Limited , Zydus Lifesciences Limited |
To see the full deal history of Bayer Zydus Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bayer Zydus Pharma Private Limited has 12 court cases on record: 8 filed by Bayer Zydus Pharma, 4 filed against it. 3 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 4 | 3 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed by the company against Satyam Drugs Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed by the company against Satyam Drugs Pvt Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed by the company against Satyam Drugs Pvt.Ltd. and 2 others | Disposed |
| District court, Chandigarh | Court case (CS CJ) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed by the company against an individual | Disposed |
To see the full case history of Bayer Zydus Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Bayer Zydus Pharma Private Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 53 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Quick India Logistics Private Limited | |||
| Saswad Tours and Travels Private Limited | |||
| Keyur Agency LLP | |||
| Neodocs Healthcare Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Bayer Zydus Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Bayer Zydus Pharma Private Limited has a workforce of 713 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
GST
Bayer Zydus Pharma has 30 GST registrations: 22 active and 8 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECB4156B1Z2 | Maharashtra | Active | 01 Jul 2017 |
| 27AAECB4156B2Z1 | Maharashtra | Active | 24 Jul 2017 |
| 03AAECB4156B1ZC | Punjab | Active | 01 Jul 2017 |
| 07AAECB4156B2Z3 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bayer Zydus Pharma Private Limited, buy the company report.
Recent activity
Bayer Zydus Pharma Private Limited has 30 board changes on record since 2011: 5 appointments and 25 cessations. The latest: Sunil Prakashlal Narwani was appointed as Additional Director on 26 May 2025.
21 earlier events are in the company report.
News
Frequently asked questions
Bayer Zydus Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 February 2011 (15+ years old) and is registered under CIN U24233MH2011PTC213118.
Bayer Zydus Pharma has 2 current directors:
- Shweta Rai - Managing Director
- Sunil Prakashlal Narwani - Additional Director
The latest financial statements of Bayer Zydus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bayer Zydus Pharma is 27AAECB4156B1Z2, registered in Maharashtra. The company has 30 GST registrations in all, of which 22 are active and 8 are cancelled or inactive. Other active GSTINs include 27AAECB4156B2Z1 (Maharashtra), 03AAECB4156B1ZC (Punjab), 07AAECB4156B2Z3 (Delhi).
The CIN (Corporate Identification Number) of Bayer Zydus Pharma is U24233MH2011PTC213118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bayer Zydus Pharma has 12 court cases on record: 8 filed by the company and 4 filed against it. 3 are pending. Most are in the district courts.
Bayer Zydus Pharma was incorporated on 07 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Bayer Zydus Pharma has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹101.49 Cr; the latest was in June 2024.
The peers of Bayer Zydus Pharma by revenue are Skites Pharma Private Limited, Dhruvi Healthcare Private Limited, Vardhman Health Specialities Private Limited, Auro Enterprises(India)Private Limited, Arihant Innochem Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sunil Prakashlal Narwani was appointed as Additional Director on 26 May 2025. Kunal Jha ceased to be Additional Director on 12 Sep 2024. Shweta Rai ceased to be Additional Director on 12 Sep 2024. Bayer Zydus Pharma has 30 board changes on record in total.
Bayer Zydus Pharma has 10 MSME Form 1 returns on record between 2019 and 2024, listing 53 overdue payments to 14 micro and small suppliers. The latest return was filed on 15 Apr 2024.
Bayer Zydus Pharma can be reached through the website bayerzyduspharma.com. Its registered office is in Thane, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
